Treatment of established tumor by adoptive immunotherapy with specifically immune T cells.
D000818:Animals; D000954:Antigens, Surface / Q000032:analysis; D002478:Cells, Cultured; D003131:Combined Modality Therapy; D003520:Cyclophosphamide; D005622:Friend murine leukemia virus; D007116:Immunization, Passive; D007167:Immunotherapy; D004915:Leukemia, Erythroblastic, Acute / Q000628:therapy; D007942:Leukemia, Experimental / Q000628:therapy*; D051379:Mice; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*
D000954:Antigens, Surface; D003520:Cyclophosphamide